Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial

被引:590
作者
Francois, Y
Nemoz, CJ
Baulieux, J
Vignal, J
Grandjean, JP
Partensky, C
Souquet, JC
Adeleine, P
Gerard, JP
机构
[1] CHU Lyon Sud, Hospices Civils Lyon, Dept Surg, F-69495 Pierre Benite, France
[2] CHU Lyon Sud, Dept Radiat Oncol, F-69495 Pierre Benite, France
[3] Hop Croix Rousse, Dept Surg, F-69317 Lyon, France
[4] Hop Croix Rousse, Dept Gastroenterol, F-69317 Lyon, France
[5] Hospices Civils Lyon EA643, Med Stat Lab, Lyon, France
[6] Clin St Marie Therese, Dept Surg, Bron, France
[7] Hop Edouard Herriot, Dept Surg, Lyon, France
关键词
D O I
10.1200/JCO.1999.17.8.2396
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The optimal timing of surgery after preoperative radiotherapy in rectal cancer is unknown. The aim of this trial was to evaluate the role of the interval between preoperative radiotherapy and surgery. Patients and Methods: patients with rectal carcinoma accessible to rectal digital examination, staged T2 to T3, NX, M0, were randomized before radiotherapy (39 Gy in 13 fractions) into two groups: in the short interval (SI) group, surgery herd ta be performed within 2 weeks after completion of radiation therapy compared with 6 to 8 weeks in the long interval (LI) group. Between 1991 and 1995, 201 patients were enrolled onto the study. Results: A long interval between preoperative radiotherapy and surgery was associated with a significantly better clinical tumor response (53.1% in the SI group v 71.7% in the LI group, P = .007) and pathologic downstaging (10.3% in the SI group v 26% in the LI group, P = .005), At a median follow-up of 33 months, there were no differences in morbidity, local relapse, and short-term survival between the two groups. Sphincter-preserving surgery was performed in 76% of cases in the LI group versus 68% in the SI group (P = 0.27). Conclusion: A long interval between preoperative irradiation and surgery provides increased tumor downstaging with no detrimental effect on toxicity and early clinical results. When sphincter preservation is questionable, a long interval may increase the chance of a successful sphincter-saving surgery. (C) 1999 by American Society of Clinical Oncology.
引用
收藏
页码:2396 / 2402
页数:7
相关论文
共 38 条
  • [1] ABEL ME, 1993, DIS COLON RECTUM, V36, P989
  • [2] Distal intramural spread in adenocarcinoma of the lower third of the rectum treated with total rectal resection and coloanal anastomosis
    Andreola, S
    Leo, E
    Belli, F
    Lavarino, C
    Bufalino, R
    Tomasic, G
    Baldini, MT
    Valvo, F
    Navarria, P
    Lombardi, F
    [J]. DISEASES OF THE COLON & RECTUM, 1997, 40 (01) : 25 - 29
  • [3] [Anonymous], LYON CHIRURG
  • [4] Preoperative radiotherapy (RT) for rectal cancer: Predictive factors of tumor downstaging and residual tumor cell density (RTCD): Prognostic implications
    Berger, C
    deMuret, A
    Garaud, P
    Chapet, S
    Bourlier, P
    ReynaudBougnoux, A
    Dorval, E
    deCalan, L
    Huten, N
    leFloch, O
    Calais, G
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (03): : 619 - 627
  • [5] Factors affecting survival after excision of the rectum for cancer - A multivariate analysis
    Bokey, EL
    Chapuis, PH
    Dent, OF
    Newland, RC
    Koorey, SG
    Zelas, PJ
    Stewart, PJ
    [J]. DISEASES OF THE COLON & RECTUM, 1997, 40 (01) : 3 - 10
  • [6] RECURRENCE RATES AFTER CURATIVE SURGERY FOR RECTAL-CARCINOMA, WITH SPECIAL REFERENCE TO THEIR ACCURACY
    CARLSSON, U
    LASSON, A
    EKELUND, G
    [J]. DISEASES OF THE COLON & RECTUM, 1987, 30 (06) : 431 - 434
  • [7] DAHL O, 1990, CANCER-AM CANCER SOC, V66, P2286, DOI 10.1002/1097-0142(19901201)66:11<2286::AID-CNCR2820661106>3.0.CO
  • [8] 2-T
  • [9] POSTOPERATIVE ADJUVANT CHEMOTHERAPY OR RADIATION-THERAPY FOR RECTAL-CANCER - RESULTS FROM NSABP PROTOCOL R-01
    FISHER, B
    WOLMARK, N
    ROCKETTE, H
    REDMOND, C
    DEUTSCH, M
    WICKERHAM, DL
    FISHER, ER
    CAPLAN, R
    JONES, J
    LERNER, H
    GORDON, P
    FELDMAN, M
    CRUZ, A
    LEGAULTPOISSON, S
    WEXLER, M
    LAWRENCE, W
    ROBIDOUX, A
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (01): : 21 - 29
  • [10] FRIC D, 1996, LYON CHIR, V92, P79